Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mochida Pharmaceutical Co., Ltd.

http://www.mochida.co.jp/english/

Latest From Mochida Pharmaceutical Co., Ltd.

CTA’s Standards For Digital Therapeutics Clears Up ‘Industry Confusion’

The Consumer Technology Association hopes its newly developed standard for digital therapeutics will clear up industry confusion and encourage the adoption of these treatments.

Digital Health Artificial Intelligence

Deal Watch: J&J Partners On Bispecific Antibody R&D With F-Star, Xencor

Janssen Biotech adds to its bispecific antibody pipeline for cancer via pair of collaborations. Ipsen and Accent pair up to investigate new target for acute myeloid leukemia.

Deal Watch Business Strategies

Takeda Continues Recent Gene Therapy Partnering Spree With Poseida Pact

Takeda will use Poseida’s non-viral delivery and gene-editing capabilities for six liver- and hematopoietic stem cell-targeted gene therapies. The agreement follows recent gene therapy tie-ups with Selecta and Genevant.

Gene Therapy Deals

Transcenta Among Chinese Biotechs Raising Funds Through Public Offerings, Private Financings

A combined $447.2m are raised through a Hong Kong initial public offering (IPO) and venture capital and private equity deals.

China Financing
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Mochida Pharmaceutical Plant Co., Ltd.
    • Mochida Healthcare Co., Ltd.
UsernamePublicRestriction

Register